RenovoRx Inc (RNXT) Stock Price, Quote, News & History

RNXTNASDAQ
$1.67
0.1912.84%
At close: Aug 28, 5:00 PM EST
$1.66
-0.01-0.6%
After Hours: Aug 28, 7:58 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-11.87M
Investing Cash Flow (TTM)
-71.00K
Financing Cash Flow (TTM)
9.10M
Free Cash Flow (TTM)
-11.94M
Capital Expenditure (TTM)
-71.00K
Net Change in Cash (TTM)
-2.84M

Analyst Trends and Forecast

2
Apr
1
Jun
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$66.05M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
29.72
PB Ratio (TTM)
7.44
Earnings Yield % (TTM)
-20.95%
Earnings Yield % (FWD)
-18.24%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.20

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$9.48M
Debt to Equity
0.04
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.48
Close
$1.67
Volume / Avg.
1.05M / 350.49K
Day Range
$1.47 - $1.68
52 Wk Range
0.70 - 1.56
Market Cap
$74.91M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
74
Short Interest
1.54%
Days to Cover
1.22

About

Sector
Health Care
Industry
Biotechnology
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Tr...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy RenovoRx (RNXT) stock?

A

You can purchase shares of RenovoRx (NASDAQ:RNXT) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for RenovoRx (RNXT) stock?

A

RenovoRx has a consensus price target of $7.17.

Q

What is the current price for RenovoRx (RNXT)?

A

The stock price for RenovoRx (NASDAQ: RNXT) is $1.66 last updated August 28, 2026 at 7:58 PM EDT.

Q

Does RenovoRx (RNXT) pay a dividend?

A

There are no upcoming dividends for RenovoRx.

Q

When is RenovoRx (NASDAQ:RNXT) reporting earnings?

A

RenovoRx does not have any upcoming earnings scheduled.

Q

Is RenovoRx (RNXT) going to split?

A

There is no upcoming split for RenovoRx.

Q

What sector and industry does RenovoRx (RNXT) operate in?

A

RenovoRx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.